(Q42693551)

4 November 2017

Effects of acute relapses on neuropsychological status in multiple sclerosis patients (English)

1 reference

4 November 2017

1 reference

1 reference

S A Morrow

1

1 reference

4 November 2017

S Jurgensen

2

1 reference

4 November 2017

F Forrestal

3

1 reference

4 November 2017

Frederick E Munchauer

4

1 reference

4 November 2017

R H B Benedict

5

1 reference

4 November 2017

8 March 2011

1 reference

4 November 2017

1 reference

4 November 2017

258

1 reference

4 November 2017

9

1 reference

4 November 2017

1603-1608

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-011-5975-3

4 November 2017

0 references

cites work

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Reliable screening for neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Within session practice effects on the PASAT in clients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Neuropsychological deficits in multiple sclerosis after acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Acute optic neuritis. A cognitive and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

How to detect cognitive dysfunction at early stages of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Effect of corticosteroids on short-term and long-term memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5975-3

21 January 2018

1 reference

12 December 2020

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis: the effect of pharmacological interventions

1 reference

12 December 2020

The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

1 reference

12 December 2020

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

1 reference

12 December 2020

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

1 reference

12 December 2020

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

1 reference

12 December 2020

10.1007/S00415-011-5975-3

Identifiers

DOI

1 reference

4 November 2017

1 reference